Progestogen-Only Contraceptives Linked to Higher Risk of Breast Cancer
Researchers found a similarly increased risk of breast cancer for progestogen-only contraceptives and oral combined contraceptives.
Diagnosis & Disease Information
Mammography Use Remains Low in American Indian Women
Mammography use is still higher among White patients than among American Indian patients, but the gap is narrowing due to declining mammography use in White patients.
Pentagon Study Finds Higher Cancer Rates Among Pilots, Ground Crews
Military pilots and the ground crews who fuel and maintain their aircraft have higher rates of certain cancers, a new study shows.
Adverse Birth Outcomes More Common Among AYAs With Cancer During Pregnancy
Adolescent and young adult patients diagnosed with cancer during pregnancy have a higher risk of adverse birth outcomes, a study suggests.
Discrimination Tied to Frailty in African-American Cancer Survivors
Among African-American cancer survivors, experiencing discrimination is associated with frailty, a study suggests.
Low-Dose Tamoxifen Reduces Risk of Breast Cancer Long-Term
Low-dose tamoxifen reduces the risk of breast cancer among patients with intraepithelial neoplasia for several years, data suggest.
Clinical Trial: Adding Vorinostat to Pembrolizumab and Tamoxifen in ER+ Breast Cancer
Researchers are conducting a phase 2 trial to test pembrolizumab and tamoxifen, with or without vorinostat, in patients with ER+ breast cancer.
Clinical Trial: Valemetostat Plus Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer
Researchers are testing valemetostat plus trastuzumab deruxtecan in patients with HER2-low/ultra-low/null metastatic breast cancer.
Clinical Trial: Tucatinib Plus Alpelisib in PIK3CA-Mutant, HER2+ Breast Cancer
Researchers are conducting a phase 1b/2 trial to test tucatinib plus alpelisib in patients with advanced, PIK3CA-mutant, HER2+ breast cancer.
Clinical Trial: CAR-T Cells in Mesothelin-Expressing Triple-Negative Breast Cancer
Researchers are conducting a phase 1 trial to test CAR T-cell therapy in patients with mesothelin-expressing triple-negative breast cancer.
- Loading...
Loading...
Next post in Breast Cancer
Loading... 
Loading...